Hemosiderosis
Showing 1 - 25 of 72
Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)
Recruiting
- Idiopathic Pulmonary Hemosiderosis
- Leflunomide
- Leflunomide
- Steroid Drug
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023
Iron Deposits in Pancreas by MRI Method of Dialysis
Not yet recruiting
- Iron Deposition
- +2 more
- MRI
-
Quincy-sous-Sénart, FranceHôpital Privé Claude Galien
Oct 20, 2022
"Iron Overload and Endocrinological Diseases"
Recruiting
- Iron Overload
- +4 more
-
Modena, ItalyUnit of Endocrinology of Azienza Ospedaliero-Universitaria di Mo
Nov 13, 2023
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients
Completed
- Steatohepatitis, Nonalcoholic
- +4 more
-
Fort Sam Houston, TexasBrooke Army Medical Center
Mar 21, 2022
Hemochromatosis Trial run by the National Institutes of Health Clinical Center (CC) (Phlebotomy)
Recruiting
- Hemochromatosis
- Phlebotomy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 30, 2023
Cardiac Function in Patients With Hereditary Hemochromatosis
Completed
- Hereditary Hemochromatosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Hereditary Hemochromatosis, Hyperferritinemia Trial in Basel, Berne (Venipuncture)
Enrolling by invitation
- Hereditary Hemochromatosis
- Hyperferritinemia
- Venipuncture
-
Basel, Switzerland
- +1 more
Feb 14, 2023
Iron Deficiency Anemia of Pregnancy, Iron Storage Disease Trial in Jinan (Niferex)
Recruiting
- Iron Deficiency Anemia of Pregnancy
- Iron Storage Disease
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Apr 6, 2023
MRI QSM Imaging for Iron Overload
Recruiting
- Hemochromatosis
- Iron Overload
- Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM)
-
Stanford, California
- +1 more
Aug 2, 2022
Hereditary Hemochromatosis Trial in Melbourne (BBI-001, Original Fibre Metamucil)
Recruiting
- Hereditary Hemochromatosis
- BBI-001
- Original Fibre Metamucil
-
Melbourne, Victoria, AustraliaNucleus Networks
Jul 18, 2022
Transfusional Iron Overload, Iron Overload, Iron Chelation Trial (SPD602, Deferasirox)
Withdrawn
- Transfusional Iron Overload
- +6 more
- (no location specified)
Jun 1, 2021
Hemochromatosis Type 1 Trial in Rennes (First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7
Completed
- Hemochromatosis Type 1
- First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7 ml/kg (with a maximum of 500ml)
-
Rennes, FranceCHU Pontchaillou
Jun 8, 2021
Non-invasive Quantification of Liver Iron With MRI
Completed
- Iron Overload
- Hemosiderosis
- Non-contrast MRI
-
Madison, WisconsinWisconsin Institutes for Medical Research
Dec 4, 2019
Deferoxamine for the Treatment of Hemochromatosis
Completed
- Diabetes Mellitus
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019
Postpartum Hemorrhage, Ligation, Color Doppler Trial (Control group, BUAL group)
Not yet recruiting
- Postpartum Hemorrhage
- +3 more
- Control group
- BUAL group
- (no location specified)
Oct 19, 2022
Cognitive Functions, Psychological Symptoms, and Quality of Life
Not yet recruiting
- B Thalassemia
- Wechsler IQ for Adults
- +4 more
- (no location specified)
Oct 25, 2021
Transferrin Saturation and Asthenia in Hemochromatosis
Completed
- Hemochromatoses, Genetic
-
Rennes, Britain, FranceRennes University Hospital
Jul 30, 2019
Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)
Completed
- Transfusion-dependent Hemachromatosis
- +2 more
- Deferoxamine
- +2 more
-
Boston, MassachusettsChildren's Hospital Boston
Jun 14, 2019
Dysmetabolic Iron Overload Syndrome, Genetic Hemochromatosis, Iron Absorption Trial in Clermont-Ferrand (polyphenols, Placebo)
Completed
- Dysmetabolic Iron Overload Syndrome
- +3 more
- polyphenols
- Placebo
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Mar 29, 2019
Research Network for Neonatal Diseases Induced by Tissular
Completed
- Glomerulonephritis, Membranous
- +2 more
-
Limoges, FranceLimoges University Hospital
Jan 11, 2019
Hepatic Affection in Hemodialysis Iron Overload in Assiut
Completed
- Hepatic Injury
-
Assuit, EgyptMarwa Abokresha
Aug 25, 2021
Cellular Diffusion of Tacrolimus Across Membrane of Mononuclear
Completed
- Hemochromatosis
- Cell pharmacokinetics of tacrolimus
-
Rennes, FranceCHU de Rennes
Aug 31, 2018
Evaluate Cognitive and Brain Function of ß-thalassemia Patients.
Unknown status
- Thalassemia
- Brain Function (Measured by ERP Level)
-
Afula, IsraelHaemek Medical Center
Oct 30, 2019